The company operates in a field where spending often isn't optional.

The stock is especially attractive to income seekers.

The only healthcare stock I own is Medtronic, and I'm not planning to sell it anytime soon. I am not a scientist or a medical ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Medtronic is launching more robots. Its new atrial fibrillation tech is taking off. Yet tariffs remain a hurdle. Tariffs are ...

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, ...

Medtronic (NYSE: MDT) announced today that it received FDA premarket approval (PMA) for the use of its Infuse bone graft in ...

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, the company's growth ...

By Mike Scarcella and Blake Brittain Feb 5 (Reuters) - Medtronic owes rival medical device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for ...

On Tuesday, Medtronic disclosed its third-quarter results for fiscal year 2026, reporting a revenue of $9 billion, up 8.7% ...